BofA/Merrill Lynch Upgrades Achillion Pharmaceuticals (ACHN) to Buy

September 19, 2012 6:28 AM EDT
Get Alerts ACHN Hot Sheet
Price: $4.06 -0.73%

Rating Summary:
    14 Buy, 3 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade ACHN Now!
Join SI Premium – FREE
BofA/Merrill Lynch upgraded Achillion Pharmaceuticals (NASDAQ: ACHN) from Underperform to Buy.

For an analyst ratings summary and ratings history on Achillion Pharmaceuticals click here. For more ratings news on Achillion Pharmaceuticals click here.

Shares of Achillion Pharmaceuticals closed at $8.10 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot Upgrades, Upgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment